PhoreMost

Recent Finacing

Series B ext

Recent Raise

$12M

PhoreMost is a Cambridge-based biopharmaceutical company that uses the SITESEEKER® platform to identify cryptic druggable sites and discover novel E3 ligases and degrader/molecular-glue therapeutics for oncology and inflammatory diseases.

Founded 2014

Cambridgeshire, United Kingdom

1-10

Private

phoremost.com

Highlights

Focus Areas

Biopharma

Biotechnology

Health Care

Recent Investors

T

Financials

$78.5M

Total Raised

4

Funding rounds

9

Investors

Team

Upgrade to view the team

See the team members at PhoreMost.